- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03146494
The Role of Thyroid Function in the Development and Prognosis of Stanford Type A Aortic Dissection.
May 7, 2017 updated by: Beijing Anzhen Hospital
A total of 300 consecutive cardiac patients will receive preoperative thyroid function profile evaluation, including 150 patients with Standford type A aortic dissection (STAAD) and 150 normal human.For one thing, we will compare the two groups and study the role of thyroid function in the develoment of STAAD.
For another, we will collect all the perioperative data of the STAAD group and study the role of thyroid function in the prognosis of STAAD.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100069
- Recruiting
- Wenjian Jiang
-
Contact:
- Wenjian Jiang, M.D.
- Phone Number: +8618810252631
- Email: jwj87427@126.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
A total of 300 consecutive cardiac patients will receive preoperative thyroid function profile evaluation, including 150 patients with Standford type A aortic dissection (STAAD) and 150 normal human.
Description
Inclusion Criteria:
Adult patients with STAAD will underwent aortic surgery who are willing and able to give informed consent for participation in the study.
Exclusion Criteria:
The main initial exclusion criteria included clinical evidence of sepsis or cachexia or concomitant presence of any predominant severe systemic disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Normal
|
|
STAAD
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Role of Thyroid Function in the Development of STAAD.
Time Frame: 30 days
|
Patients were followed for 30-day mortality and major adverse events (MAEs) as defined by the need for rethoracotomy, occurrence of postoperative heart failure, neurologic deficit, lung failure, renal failure, or sepsis.
|
30 days
|
|
The Role of Thyroid Function in the Prognosis of STAAD.
Time Frame: 30 days
|
Patients were followed for 30-day mortality and major adverse events (MAEs) as defined by the need for rethoracotomy, occurrence of postoperative heart failure, neurologic deficit, lung failure, renal failure, or sepsis.
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2015
Primary Completion (Anticipated)
September 1, 2017
Study Completion (Anticipated)
September 1, 2017
Study Registration Dates
First Submitted
May 7, 2017
First Submitted That Met QC Criteria
May 7, 2017
First Posted (Actual)
May 10, 2017
Study Record Updates
Last Update Posted (Actual)
May 10, 2017
Last Update Submitted That Met QC Criteria
May 7, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Beijing Anzhen Hospital
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stanford Type A Aortic Dissection
-
Second Affiliated Hospital, School of Medicine,...Tongji Hospital; The Affiliated Hospital of Qingdao University; The Affiliated... and other collaboratorsNot yet recruitingStanford Type A Aortic Dissection | Acute Type A Aortic Dissection | Postoperative Aortic Dissection Follow-up
-
The First Hospital of Hebei Medical UniversityCompletedAcute Stanford Type A Aortic DissectionChina
-
Yunlong FanCompletedCumulative Sum Learning Curves | Stanford Type A Aorta DissectionChina
-
Hangzhou Endonom Medtech Co., Ltd.RecruitingChronic Stanford B Type Aortic Dissection Proximal TearChina
-
Centre Hospitalier Universitaire DijonRecruitingType A Aortic Dissection With Residual Type B Dissection | Chronic Type B Aortic DissectionFrance
-
West China HospitalNot yet recruitingResidual Dissection After Repair for Type A Aortic DissectionChina
-
Centre Cardiologique du NordUniversita degli Studi di Genova; Campus Bio-Medico University; Henri Mondor... and other collaboratorsEnrolling by invitationAortic Valve Insufficiency | Type B Aortic Dissection | Aortic Diseases | Ascending Aortic Dissection | Aortic Arch | Aortic Root Dissection | Aortic Root Dilatation | Type A Aortic DissectionFrance
-
Nanjing Medical UniversityBeijing Anzhen HospitalCompletedAcute Aortic Syndrome | Type a Aortic DissectionChina
-
Helsinki University Central HospitalAssistance Publique - Hôpitaux de Paris; Universitaire Ziekenhuizen KU Leuven; Azienda Ospedaliera Universitaria Integrata Verona and other collaboratorsCompletedType A Aortic DissectionSpain, Belgium, Finland, United Kingdom, Germany, Italy, Czechia, France
-
First Affiliated Hospital Xi'an Jiaotong UniversityCompleted